Summary
Nine patients who underwent heart transplantation (one female; average age 48 ± 11, range 19–58 years) were followed in respect to contents of right-sided heart septum, blood and plasma ubiquinone (UQ), plasma α-tocopherol (αT), and plasma free cholesterol (FC). In contrast to healthy persons, substantial inter- and intraindividual variations were observed; individually low values were seen with rejection. Heart muscle UQ in well-treated patients averaged 0.33 ± 0.08, range 0.06–0.58 μg mg−1 (0.38 ± 0.09 μmol g−1 dry weight) and was not different from healthy individuals. Plasma UQ, αT; and FC averaged 0.63 ± 0.33 μg ml−1 (P < 0.05 versus sedentary controls), 8.1 ± 4.0 μg ml−1 (P < 0.01), and 0.52 ± 0.23 mg ml−1 (P < 0.05). Corresponding molar values were 0.73 ± 0.37 (UQ), 2.0 ± 1.1 μmol l−1 (αT), and 1.42 ± 0.54 mmol 1−1 (FC). Blood and plasma UQ values were identical. A saturationlike relationship was found between heart and blood UQ: blood contents below 0.7 μg ml−1 (0.8 μmol l−1) corresponded to markedly lowered heart contents. In four patients in whom blood samples were taken close to a fatal complication it averaged 0.42 μg ml−1 (0.49 μmol l−t, P < 0.01). When low heart muscle and blood ubiquinone were present, other variables such as left ventricle cardiac output or cycle ergometer performance was markedly impaired. Plasma UQ and off covaried with a marker of the lipoidal deposit volume, plasma FC. The ratios UQ and αT over FC (N-UQ and N-αT) are alternative means for clinical evaluation. Mean N-αT was relatively more depleted than N-UQ. On an individual basis this was more pronounced for those with low N-UQ than for those with high values.
Similar content being viewed by others
Abbreviations
- αT:
-
α-tocopherol
- FC:
-
free cholesterol
- HTX:
-
cardiac transplantation
- UQ:
-
ubiquinone
- N-αT:
-
αT/FC ratio
- N-UQ:
-
UQ/FC ratio
- WOBLD :
-
exercise to onset of blood lactate accumulation
- WSL :
-
exercise to symptom limitation
References
Appelkvist E-L, Karlén A, Dallner G (1991) Biosynthesis and regulation of coenzyme Q. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Beyer RE, Ernster L (1990) The antioxidant role of coenzyme Q. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Beyer RE, Nordenbrand K, Ernster L (1986) The role of coenzyme Q as a mitochondrial antioxidant: a short review. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Crane FL (1986) Physiological coenzyme Q function and pharmacological reactions. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Edlund P-O (1988) Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 425:87–97
Elmberger PG, Kalén A, Appelkvist EL, Dallner G (1987) In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur J Biochem 168:1–11
Elmberger PG, Kalén A, Brunk U, Dallner G (1989) Discharge of newly-synthesized dolichol and ubiquinone with liporproteins to rat liver perfusate and to the bile. Lipids 24:919–930
Ernster L, Beyer RE (1991) Antioxidant functions of coenzyme Q: some biochemical and pathophysiological implications. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Esterbauer H, Waeg G, Puhl H, Dieber-Rotheneder M (1990) Mechanism of oxidation of low density lipoproteins. In: Ingelman-Sundberg M, Gustafsson J-Å, Orrenius S (eds) Drug metabolizing enzymes: genetics, regulation and toxicology. Karolinska Institute, Stockholm
Folkers K, Langsjoen P, Willis R, Richardson P, Xia L-J, Ye CQ, Tamagawa H (1990) Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 87:8931–8934
Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412–426
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Hess ML, Manson NH (1984) Molecular oxygen: friend and foe. J Mol Cell Cardiol 19:969–985
Hess ML, Okabe E, Ash P, Kontos HA (1984) Free radical mediation of the effects of acidosis on calcium transport by cardiac sarcoplasmic reticulum in whole heart homogenates. Cardiovasc Res 18:149–157
Horwitt MK, Harvey CC, Dahm CH, Searcy MT (1972) Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. NY Acad Sci 203:223–236
Jackson RL, Morrisett JD, Gotto AM (1976) Lipoprotein structure and metabolism. Physiol Rev 56:259–316
Johansen K, Theorell H, Karlsson J, Diamant B, Folkers K (1991) Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann Med 23:649–656
Kalén A, Appelkvist E-L, Dallner G (1987) Biosynthesis of ubiquinone in rat liver. Acta Chem Scand 41:70–72
Kalén A, Norling B, Appelkvist E-L, Dallner G (1987) Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim Biophys Acta 926:70–78
Karlsson J (1985) Metabolic adaptations to exercise: a review of potential beta-adrenoceptor antagonist effects. Am J Cardiol 55[suppl D]:48–58
Karlsson J (1986) Muscle fiber composition, metabolic potentials, oxygen transport and exercise performance in man. In: Benzi G, Packer L, Siliprandi H (eds) Biochemical Aspects of Physical Exercise. Elsevier, Amsterdam
Karlsson J (1987) Heart and skeletal muscle ubiquinone or CoQ10 as a protective agent against radical formation in man. In: Benzi (ed) Advances in Myochemistry. Libbey, London
Karlsson J, Folkers K, Åström H, Jansson E, Pernow B, Holmgren A, Mellstedt H, Diamant B (1986) Effect of Adriamycin on heart and skeletal muscle Q in man. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Karlsson J, Diamant B, Folkers K (1989) Skeletal muscle characteristics of significance for metabolism in health and disease. In: Benzi G (ed) Advances in myochemistry. Libbey, London
Karlsson J, Diamant B, Folkers K, Edlund P-O, Lund B, Theorell B (1990) Plasma ubiquinone and cholesterol contents with and without ubiquinone treatment. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Karlsson J, Diamant B, Folkers K, Edlund P-O, Lund B, Theorell B (1990) Skeletal muscle and blood CoQ10 in health and disease. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Karlsson J, Diamant B, Theorell H, Folkers K (1991) Skeletal muscle coenzyme Q10 in healthy man and selected patient groups. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q, vol VI. Elsevier, Amsterdam
Karlsson J, Diamant B, Folkers K, Åström H, Gunnes S, Liska J, Semb B (1992) Ischemic heart disease, skeletal muscle fibers and exercise capacity. Eur Heart J 13:758–762
Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K (1992) Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases In: Packer L, Fuchs J (eds) Vitamin E: biochemistry and clinical applications. Dekker, New York
Langsjoen PH, Langsjoen PH, Folkers K (1990) Long-term efficacy and safety of coenzyme Q10 therapy for idiopatic dilated cardiomyopathy. Am J Cardiol 65:521–523
Lin L, Sotonyi P, Somogyi E, Karlsson J, Folkers K, Nara Y, Sylvén C, Kaijser L, Jansson E (1988) Coenzyme Q10 content in different parts of the normal human heart. Clin Physiol 8:391–398
Mortensen SA (1989) Endomyocardial biopsy. Laegeforeningens, Copenhagen
Mortensen SA, Bouchelouche P, Muratso K, Folkers K (1986) Clinical decline and relapse of cardiac patients on coenzyme Q withdrawal. In: Folkers K, Yamamyra Y (eds) Biomedical aspects of coenzyme Q. Elsevier, Amsterdam
Mortensen SA, Heidt P, Sehested J (1990) Clinical perspectives in the treatment of cardiovascular diseases with coenzyme Q10. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Packer L, Kagan V, Serbinova E (1991) Participation of ubiquinones in membrane antioxidation: direct radical scavenging or tocopherol recycling. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Ramasarma T (1985) Natural occurrence and distribution of coenzyme Q. In: Lenaz G (ed) Coenzyme Q. Wiley, New York
Vadhanavikit S, Morishita M, Duff GA, Folkers K (1984) Microanalyses for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts. Biochem Biophys Res Commun 123:1165–1169
Willis RA, Folkers K, Tucker JL, Xia LJ, Tamagawa H (1990) Lovastatin decreases coenzyme Q levels in rats. Proc Natl Sci USA 87:8928–8930
Author information
Authors and Affiliations
Additional information
The study was carried out by the Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden
Rights and permissions
About this article
Cite this article
Karlsson, J., Liska, J., Gunnes, S. et al. Heart muscle ubiquinone and plasma antioxidants following cardiac transplantation. Clin Investig 71 (Suppl 8), S76–S83 (1993). https://doi.org/10.1007/BF00226845
Issue Date:
DOI: https://doi.org/10.1007/BF00226845